In 2019 , U.S. biotech companies raised some 5.6 billion U.S. dollars of capital through initial public offerings ( IPOs ) , while they received some 14.9 billion U.S. dollars in risk capital . This statistic contains the financing data of U.S. biotech companies from 2015 to 2019 , by type .
